Current Activities

Mashup Score: 0

Tweetorial 3: Not Just Another Monoclonal Antibody: Best Practices for Providing T-cell Therapies — Current Activities - 7 month(s) ago

Differentiating Bispecifics & CAR-T for Relapsed Refractory Multiple Myeloma Tweetorial 3: Not Just Another Monoclonal Antibody: Best Practices for Providing T-cell Therapies This activity is jointly provided by Global Education Group and Bonum…

Source: Current Activities

Categories: Hem/Oncs, Latest Headlines

Tweet Tweets with this article
- NoopurRajeMD
  
  2/#MMsm @BonumCE @Global_CME ⚠️Important "need to know" items👇 1️⃣ - read CME ℹ️👉🏼https://t.co/q4DprzNF7G 2️⃣ - take the Pre-survey: https://t.co/1vp73c6uUt 3️⃣ - get all the info 👇 4️⃣ - claim your #CME 🏆 https://t.co/BITxNCTzHW
- NoopurRajeMD
  
  #mmsm ↪️ Need on the who, what, where, how to provide #BCMA-directed T-cell tx for #Myeloma? 📚 Lots to learn w @mvmateos & me 👇#MedTweetorial🧵 🏆 🆓#CME 👉🏼https://t.co/q4DprzNF7G Supported by educational grants from @JanssenUS & @Pfizer 🏁What’s your specialty?

Mashup Score: 3

HCM in IBD — Current Activities - 7 month(s) ago

Real-world Access to T cell-directed Therapies in Multiple Myeloma: Driving Away Health Disparities This activity is jointly provided by Global Education Group and Bonum CE. …

Source: Current Activities

Categories: Hematologists1, Latest Headlines

Tweet Tweets with this article
- jmikhaelmd
  
  2/@BonumCE @Global_CME #mmsm ⚠️Important "need to know" items👇 1️⃣ - read CME ℹ️👉🏼https://t.co/W7S6rrN2FJ 2️⃣ - take the Pre-survey: https://t.co/vxR0PL3yeH 3️⃣ - get all the info 👇 4️⃣ - claim your 🏆 https://t.co/J2OJdRrcEP
- jmikhaelmd
  
  Did u know incidence of #myeloma is >2️⃣x ⬆️in African American than in White ppl in🇺🇸? ☑️ out #mmsm Disparities & Access #MedTweetorial🧵w @MaiolinoAngelo & Me👋 🆓#CME 👉🏼 https://t.co/W7S6rrN2FJ Support by edu grants from @JanssenUS & @Pfizer 🏁First, what’s ur specialty?

Mashup Score: 1

HCM in IBD — Current Activities - 7 month(s) ago

BCMA-directed T-cell therapies: Driving Home the Differences Between CARs & Bispecific Antibodies This activity is jointly provided by Global Education Group and Bonum CE. …

Source: Current Activities

Categories: Hem/Oncs, Latest Headlines

Tweet Tweets with this article
- jmikhaelmd
  
  2/⚠️Important "need to know" bits👇 1️⃣ - read CME ℹ️👉🏼https://t.co/sAYnYHT7XH 2️⃣ - take the Pre-survey: https://t.co/5NHyH4LFpW 3️⃣ - get all the info 👇 4️⃣ - claim your 🏆 https://t.co/1mLAgkWmzF
- NoopurRajeMD
  
  2/⚠️Important "need to know" bits👇 1️⃣ - read CME ℹ️👉🏼https://t.co/DMcYrvU6fn 2️⃣ - take the Pre-survey: https://t.co/sPtjagLqwW 3️⃣ - get all the info 👇 4️⃣ - claim your 🏆 https://t.co/Es0rJiUaQ6
- jmikhaelmd
  
  🧢s off to FDA & EMA Busy 🗓️in #MultipleMyeloma 🆕ℹ️#mmsm BCMA🎯 T-cell tx @NoopurRajeMD & me will catch u🆙 #MedTwitter #CME series w diff btwn CARs & Bispecific Antibodies 🆓CME👉🏼https://t.co/sAYnYHT7XH Supported by edu grants from @JanssenUS & @Pfizer 📍What’s ur specialty?
- NoopurRajeMD
  
  🧢s off to FDA & EMA Busy 🗓️in #MultipleMyeloma 🆕ℹ️#mmsm BCMA🎯 T-cell tx @jmikhaelmd & me will catch u🆙 #MedTwitter #CME series w diff btwn CARs & Bispecific Antibodies 🆓CME👉🏼https://t.co/DMcYrvU6fn Supported by edu grants from @JanssenUS & @Pfizer 📍What’s ur specialty?

Mashup Score: 0

HCM in IBD — Current Activities - 9 month(s) ago

BCMA-directed T-cell therapies: Driving Home the Differences Between CARs & Bispecific Antibodies This activity is jointly provided by Global Education Group and Bonum CE. …

Source: Current Activities

Categories: Hematologists1, Latest Headlines

Tweet Tweets with this article
- jmikhaelmd
  
  RT @NoopurRajeMD: 2/⚠️Important "need to know" bits👇 1️⃣ - read CME ℹ️👉🏼https://t.co/DMcYrvTypP 2️⃣ - take the Pre-survey: https://t.co/sP…

Mashup Score: 6

HCM in IBD — Current Activities - 9 month(s) ago

BCMA-directed T-cell therapies: Driving Home the Differences Between CARs & Bispecific Antibodies This activity is jointly provided by Global Education Group and Bonum CE. …

Source: Current Activities

Categories: Hematologists1, Latest Headlines

Tweet Tweets with this article
- jmikhaelmd
  
  2/⚠️Important "need to know" bits👇 1️⃣ - read CME ℹ️👉🏼https://t.co/sAYnYHSA89 2️⃣ - take the Pre-survey: https://t.co/5NHyH4L7Ao 3️⃣ - get all the info 👇 4️⃣ - claim your 🏆 https://t.co/MyKSGZWgOY
- jmikhaelmd
  
  #MedTwitter have ?s about #MultipleMyeloma BCMA🎯 T-cell tx? Don't 🥵@NoopurRajeMD & me have u covered 💃off our #mmsm #CME series w diff btwn CARs & Bispecific Antibodies 🆓CME👉🏼https://t.co/sAYnYHSA89 Supported by edu grants from @JanssenUS & @Pfizer 📍What’s ur specialty?
- NoopurRajeMD
  
  2/⚠️Important "need to know" bits👇 1️⃣ - read CME ℹ️👉🏼https://t.co/DMcYrvTypP 2️⃣ - take the Pre-survey: https://t.co/sPtjagKSHo 3️⃣ - get all the info 👇 4️⃣ - claim your 🏆 https://t.co/ErSjKgK6fj
- NoopurRajeMD
  
  #MedTwitter have ?s about #MultipleMyeloma BCMA🎯 T-cell tx? Don't 🥵@JMikhaelMD & me have u covered 💃off our #mmsm #CME series w diff btwn CARs & Bispecific Antibodies 🆓CME👉🏼https://t.co/DMcYrvTypP Supported by edu grants from @JanssenUS & @Pfizer 📍What’s ur specialty?

Mashup Score: 0

COVID Hosp Expert Roundtable — Current Activities - 11 month(s) ago

Seeing the Forest Through the Trees: Therapeutic Approaches for Hospitalized Patients with COVID-19 This activity is jointly provided by National Jewish Health (NJH) and Bonum CE. …

Source: Current Activities

Categories: Critical Care, Latest Headlines

Tweet Tweets with this article
- NidaQadirMD
  
  Coming soon... 🏥#MedTwitter Expert Roundtable - Hosp'd Pts w COVID-19 w/⭐️me, @WrayCharles +@DrOnyemaOgbuagu Supported by an edu grant from #Gilead Sci, Inc 📝Next... 1:🟢Answer PRE-polls👇 OR 🆓 #CME👉https://t.co/6NDVz7qZMc 2:🗓️Watch video 3:🔴Answer post-polls 4:🏆Claim CME

Mashup Score: 0

COVID Hosp Expert Roundtable — Current Activities - 11 month(s) ago

Seeing the Forest Through the Trees: Therapeutic Approaches for Hospitalized Patients with COVID-19 This activity is jointly provided by National Jewish Health (NJH) and Bonum CE. …

Source: Current Activities

Categories: Infectious Disease, Latest Headlines

Tweet Tweets with this article
- DrOnyemaOgbuagu
  
  Coming soon... 🏥#MedTwitter Expert Roundtable - Hosp'd Pts w COVID-19 w/⭐️Me @NidaQadirMD + @WrayCharles Supported by an edu grant from #Gilead Sci, Inc 📝Next... 1:🟢Answer PRE-polls👇 OR 🆓 #CME👉https://t.co/3A5d2wjIDq 2:🗓️Watch video 3:🔴Answer post-polls 4:🏆Claim CME

Mashup Score: 2

22012a - Crack the Case #2 — Current Activities - 1 year(s) ago

Seeing the Forest Through the Trees: Therapeutic Approaches for Hospitalized Patients with COVID-19 This activity is jointly provided by National Jewish Health (NJH) and Bonum CE. …

Source: Current Activities

Categories: Infectious Disease, Latest Headlines

Tweet Tweets with this article
- DrOnyemaOgbuagu
  
  Welcome back for Day2️⃣ #CrackTheCase 🏥Hospitalized Pts w/ COVID-19 - Best practices for mgmt of immunocompromised, critically-ill patients w/ ⭐️@NidaQadirMD 👉CMEℹ️🔗 https://t.co/yUGTMnfNGc https://t.co/T4v1qvalta
- NidaQadirMD
  
  Welcome back for Day2️⃣ #CrackTheCase 🏥Hospitalized Pts w/ COVID-19 - Best practices for mgmt of immunocompromised, critically-ill patients w/ ⭐️@NidaQadirMD 👉CMEℹ️🔗 https://t.co/QgXU3gMhvJ https://t.co/1doA70qiL5

Mashup Score: 2

22012a - Crack the Case #2 — Current Activities - 1 year(s) ago

Seeing the Forest Through the Trees: Therapeutic Approaches for Hospitalized Patients with COVID-19 This activity is jointly provided by National Jewish Health (NJH) and Bonum CE. …

Source: Current Activities

Categories: Infectious Disease, Latest Headlines

Tweet Tweets with this article
- DrOnyemaOgbuagu
  
  4/#MedTwitter #IDTwitter @toddlee @AneeshMehtaMD @KariTikkinen #CME🏅➡️https://t.co/yUGTMnfNGc 🟢Pre-Poll 2️⃣ For critically ill pts w COVID-19 & ARDS, which treatment/s are recommended in addition to corticosteroids? abx=antibiotic, BAR=baricitinib, TOCI= tocilizumab
- DrOnyemaOgbuagu
  
  3/#CME🏅➡️https://t.co/yUGTMnfNGc 📟Paging experts to weigh in & 💬@AngelaBrancheMD @PaulSaxMD @HelenChuMD 🟢Pre-Poll 1️⃣ What is the most appropriate treatment for hospitalized pts w COVID who require low-flow O2? DEX=Decadron/dexamethasone
- DrOnyemaOgbuagu
  
  2/#MedTwitter #IDTwitter 1️⃣Answer pre-polls👇 2️⃣Watch📽️👆 3️⃣Come back tmrw👂best practices 4️⃣Claim #CME 🏆https://t.co/yUGTMnfNGc Supported by an independent edu grant from #Gilead Sciences, Inc. 📸Faculty disclosures & #CME ℹ️ https://t.co/Pb22s601mQ
- DrOnyemaOgbuagu
  
  #MedTwitter #IDTwitter #PulmTwitter 🤨How to manage a crit ill pt w COVID? 🗓️Join @NidaQadirMD tmrw, Day 2️⃣→learn best practices 🆓#CME👉 https://t.co/yUGTMnfNGc 🟢What's your specialty?
- NidaQadirMD
  
  4/#MedTwitter #IDTwitter @toddlee @AneeshMehtaMD @KariTikkinen #CME🏅➡️https://t.co/QgXU3gLJGb 🟢Pre-Poll 2️⃣ For critically ill pts w COVID-19 & ARDS, which treatment/s are recommended in addition to corticosteroids? abx=antibiotic, BAR=baricitinib, TOCI= tocilizumab
- NidaQadirMD
  
  3/#CME🏅➡️https://t.co/QgXU3gLJGb 📟Paging experts to weigh in & 💬 @CamWolfe @AngelaBrancheMD @doctorfungus @HelenChuMD @DrAndreKalil 🟢Pre-Poll 1️⃣ What is the most appropriate treatment for hospitalized pts w COVID who require low-flow O2? DEX=Decadron/dexamethasone
- NidaQadirMD
  
  2/#MedTwitter #IDTwitter 1️⃣Answer pre-polls👇 2️⃣Watch📽️👆 3️⃣Come back tmrw👂best practices 4️⃣Claim #CME 🏆https://t.co/QgXU3gLJGb Supported by an independent edu grant from #Gilead Sciences, Inc. 📸Faculty disclosures & #CME ℹ️ https://t.co/9pAdJbY7RC
- NidaQadirMD
  
  #MedTwitter #IDTwitter #PulmTwitter 🤨How to manage a crit ill pt w COVID? 🗓️Join tmrw, Day 2→learn best practices 🆓#CME👉 https://t.co/vXf4yYBJRB 📟Paging experts to ⚖️ in 📟@nickmmark @WesElyMD @PulmCrit @Paul_Wischmeyer @PilarRiveraOrt1 @EM_RESUS 🟢What's your specialty?

Mashup Score: 0

Crack the Case #1 — Current Activities - 1 year(s) ago

This CME-certified, video reviews a patient case and the best practices for treatment and staging based on the latest clinical guidance regarding severity assessments for hospitalized patients with COVID-19.

Source: Current Activities

Categories: Infectious Disease, Latest Headlines

Tweet Tweets with this article
- DrOnyemaOgbuagu
  
  5/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine #Hospitalists #BonumCE #FOAMCC #CME🏅➡️https://t.co/DGYeVFJ53J 🟢Pre-poll Q 2️⃣ ❓For a COVID+ patient, which of the following are considered risks for disease progression?
- DrOnyemaOgbuagu
  
  4/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine #Hospitalists @BonumCe #CME➡️https://t.co/DGYeVFJ53J 🟢Pre-Poll1️⃣ ❓@NIH guidelines recommend which tx for pts w/ mild/moderate #COVID19 infection, no O2 supp, but who have high risk for progression?
- DrOnyemaOgbuagu
  
  3/#MedTwitter #IDTwitter #IDMedEd #IDFellow #IMResident #InternalMedicine #Hospitalists @BonumCe #CME➡️https://t.co/DGYeVFJ53J 🗳️pre-polls👇 🟢What’s your specialty?
- DrOnyemaOgbuagu
  
  2/#MedTwitter #IDTwitter #IDMedEd #InternalMedicine #Hospitalists 1️⃣Answer pre-polls👇 2️⃣Watch📽️👆 3️⃣Come back tmrw👂RE: best practices in stging & mgmt 4️⃣Claim #CME https://t.co/DGYeVFJ53J 📸Faculty disclosures & #CME ℹ️ Supported by an independent edu grant from #Gilead https://t.co/thzvTgUrcq